Mitochondrial Electron Transport Chain Disruption and Oxidative Stress in Lipopolysaccharide-Induced Cardiac Dysfunction in rats and mice
Agda Aline Pereira de Sousa, Leonardo da Silva ChavesiD, Heberty Tarso FacundoiD
Abstract
Sepsis, characterized by severe systemic inflammation and an excessive immune response to infection, is frequently triggered by bacterial endotoxins like lipopolysaccharide (LPS) from Gram-negative bacteria. Moreover, sepsis-induced cardiac dysfunction remains a leading cause of mortality. This study aims to elucidate the effects of LPS-induced cardiac injury on mitochondrial damage, oxidative stress, and subsequent cardiac dysfunction. LPS injections (in rats and mice) for three days (1.5 mg/kg) impacted the body weight and increased cardiac TNF-. Additionally, it decreased mitochondrial complexes I and II activities while complexes III and IV remained unaffected. Disturbed in mitochondrial electron transport chain leads to an increase in reactive oxygen species (ROS). Indeed, LPS treatment significantly increased mitochondrial hydrogen peroxide production, reduced the activity of antioxidant enzymes catalase, superoxide dismutase, glutathione peroxidase, and glutathione reductase activity. This was accompanied by decreased mitochondrial and cytosolic sulfhydryl proteins and parallel increased cellular lipid peroxidation in the presence or absence of Fe2+. LPS-treated samples had increased glutathione s-transferase activity, which may be an attempt of the cell to remove toxic lipid peroxidation products. In a more acute Langendorff-perfused rat hearts, LPS infusion (0.5 g/mL) induced a significant elevation in left ventricular end-diastolic pressure and a decrease in left ventricular developed pressure. These findings elucidate the harmful mitochondrial and oxidative effects of LPS in cardiac tissue and could help the development of targeted therapies to mitigate the adverse effects of sepsis-induced cardiac dysfunction.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 5
- FWCI
- 1.49
- Field percentile
- top 20%
- Organism
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Mitochondrial-targeted therapy with elamipretide preserves cardiac function and prevents late mortality in murine sepsis-induced cardiac dysfunction.
Jennie Vu, Cory S. Wagg, … Stephane L. Bourque·bioRxiv·Jul 9, 2026
- Heme drives cardiac endothelial senescence in sepsis via STING activation
Tingting Li, Peilin Zhu, … Xiaohui Wang·Cell Death and DiseasePeer-reviewed·Dec 18, 2025
- Interleukin-35 pretreatment attenuates lipopolysaccharide-induced heart injury by inhibition of inflammation, apoptosis and fibrosis
Huanhuan Hu, Yang Fu, … Yanqing Wu·International ImmunopharmacologyPeer-reviewed·Jul 14, 2020
- Mitochondrial instability contributes to IFN-driven heart disease.
Arati Naveen Kumar, Amelia Meecham, … Caroline Anne Jefferies·bioRxiv·Sep 15, 2025
- Hepatic IRE1 Protects Against Septic Cardiac Failure
M. Li, R. R. Berton, … L. Yang·bioRxiv·Mar 14, 2023
- Citrate synthase improves sepsis-induced lung injury by reconstructing the mitochondrial tricarboxylic acid cycle of macrophages
Jiaojiao Sun, Sihao Jin, Zhiqiang Wang·The Journal of Trauma: Injury, Infection, and Critical CarePeer-reviewed·Aug 28, 2025